Microarrays & Multiplexing
News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
PathogenDx Gets CE Mark for Microarray-Based COVID-19 Test
The test has also received Emergency Use Authorization from the US Food and Drug Administration and detects SARS-CoV-2 within three hours of RNA extraction.
Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US
Based on Cytox's GenoScore platform, IBX will provide a laboratory-developed test at its CLIA-certified, CAP-accredited lab in Piscataway, New Jersey.
The firm has launched a validation trial for its in-development QuantiDNA cell-free DNA chemotherapy response assay in late-stage smoking-related cancers.
The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals.
Visby Medical Wins $12.3M BARDA Contract for Coronavirus, Flu Combo Test
The test, a version of the company's rapid SARS-CoV-2 assay, will be designed for both point-of-care and at-home use as an over-the-counter product.